Cite
HARVARD Citation
Marsilio, I. et al. (n.d.). P329 Comparative Assessment of Adalimumab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. p. S353. [Online].